News
Important Only
Stocks
Don't You Dare Buy the Cheapest Cruise Line Stock
Key PointsNorwegian Cruise Line trades for much lower revenue and forward earnings multiples than its peers.It has declined over the past year, a sharp contrast to the double-digit gains by Carnival, Royal Caribbean, and Viking.It will have a lot to prove when it offers up its fourth-quarter results...The Motley Fool
Wed, Feb 4
Other
Oncolytics Biotech® Receives FDA Fast Track Designation For Pelareorep In 2L Kras-Mutant Mss Metastatic Colorectal Cancer
Feb 4 (Reuters) - Oncolytics Biotech Inc ONCY.O:ONCOLYTICS BIOTECH® RECEIVES FDA FAST TRACK DESIGNATION FOR PELAREOREP IN 2L KRAS-MUTANT MSS METASTATIC COLORECTAL CANCERONCOLYTICS BIOTECH INC - TO LAUNCH CONTROLLED STUDY IN SECOND-LINE KRAS-MUTANT MSS MCRC WITH INTERIM DATA EXPECTED BY END OF 2026Reuters
Wed, Feb 4
Commodities
CK Hutchison launches arbitration over Panama Canal ports contract ruling
CK Hutchison disputes Panama court's annulment of port licensesChina warns Panama of consequences for court rulingPanama's president rejected Beijing's criticism, warningU.S. lawmakers see court decision as strategic winBy Clare Jim and Kane Wu HONG KONG, Feb 4 (Reuters) - Hong Kong&#...Reuters
Wed, Feb 4
Other
CORRECTED-Johnson Controls beats Q1 EPS estimates; ups FY profit view
OverviewIreland-based energy solutions provider's Q1 sales rose 7% but missed analyst expectationsAdjusted EPS of $0.89 for Q1 beat analyst expectationsCompany raised FY26 adjusted EPS guidance to $4.70 from $4.55OutlookJohnson Controls raises FY26 adjusted EPS guidance to $4.70 from $4.55Compan...Reuters
Wed, Feb 4
Forex
USD/CHF trades flat as US labor data disappoints, SNB remains vigilant
USD/CHF trades without a clear trend around 0.7750 on Wednesday at the time of writing, showing an almost unchanged performance on the day. The pair remains trapped in a narrow range as the US Dollar (USD) struggles to find a clear catalyst following the release of mixed US macroeconomic data.
Fxstreet
Wed, Feb 4
Other
REFILE-CDW beats fourth-quarter estimates on resilient demand for IT solutions
Feb 4 (Reuters) - CDW CDW.O beat fourth-quarter sales and profit estimates on Wednesday, as clients continue to invest in artificial intelligence and cloud adoption.Shares of the Vernon Hills, Illinois-based company rose 5.8% in premarket trading. The IT solutions provider has benefited from demand ...Reuters
Wed, Feb 4
Other
Golden Sun Technology Group Ltd - Changed Corporate Name From “Golden Sun Health Technology Group Limited” To “Golden Sun Technology Group Limited”
Feb 4 (Reuters) - Golden Sun Technology Group Ltd GSUN.O:GOLDEN SUN TECHNOLOGY GROUP LTD - CHANGED CORPORATE NAME FROM “GOLDEN SUN HEALTH TECHNOLOGY GROUP LIMITED” TO “GOLDEN SUN TECHNOLOGY GROUP LIMITED”GOLDEN SUN TECHNOLOGY GROUP LTD - COMPANY’S CLASS A ORDINARY SHARES WILL BE TRADED UNDER THE NEW...Reuters
Wed, Feb 4
Other
Lawmakers urge Trump to drop proposal to slash vehicle fuel economy rules
Proposed rule might cut upfront vehicle costs by $930 but raise long-term fuel expensesEx-president Biden's rules encouraged EV production without ending gas vehicles immediatelyNHTSA plans to revise heavy-duty trucks and passenger vans standards tooBy David Shepardson WASHINGTON, Feb 4 (Reut...Reuters
Wed, Feb 4
Stocks
Yum Brands falls after Q4 profit miss
Shares of KFC parent Yum Brands YUM.N slide 1.1% to $157 in volatile premarket tradingCo reports Q4 adj. EPS of $1.73, missing analysts' average estimate of $1.77, according to data compiled by LSEGPosts global same-store sales rise of 3% for the fourth quarter, compared with analysts' estim...Reuters
Wed, Feb 4
Stocks
Sarepta rises on NZ regulatory nod to start Huntington's disease trial
Shares of Sarepta Therapeutics SRPT.O 3% at $20.92 premarketDrugmaker says it received approval in New Zealand to begin first human study of SRP‑1005 for Huntington's disease, a rare fatal brain disorderCo's SRP‑1005 is an experimental treatment designed to target the genetic cause of the c...Reuters
Wed, Feb 4
Other
PRESS DIGEST-Canada - February 4
Feb 4 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.THE GLOBE AND MAILCanada Enterprise Emergency Funding Corporation (CEEFC) has named the career risk-management professional Lorraine Aud...Reuters
Wed, Feb 4
Other
Core AI Plans Partnership With Premier Data Center Developer To Speed AI Infrastructure Expansion In Malaysia
Feb 4 (Reuters) - Core AI Holdings Inc CHAI.O:CORE AI ANNOUNCES PLANNED PARTNERSHIP WITH PREMIER DATA CENTER DEVELOPER TO ACCELERATE AI INFRASTRUCTURE EXPANSION IN MALAYSIACORE AI HOLDINGS INC - COLLABORATION AIMS FOR OPERATIONAL READINESS IN 12 MONTHSReuters
Wed, Feb 4
Other
Nasdaq proposes "fast entry" rule to speed up inclusion of large new listings
Feb 4 (Reuters) - Nasdaq NDAQ.O has proposed a new rule to speed up the addition of newly listed large companies to its index, seeking to address delays that have left major IPOs and exchange transfers outside the benchmark for months.The proposal comes as 2026 is shaping up to be one of the busiest...Reuters
Wed, Feb 4
Commodities
Equinor cuts buybacks by 70% and flags sharp drop in capital expenditure next year
Quarterly pretax earnings drop 22% to $6.2 billionShare buybacks reduced to $1.5 billion from $5 billion in 2025Plans $4 billion cut to capital expenditure for 2027 Aims to keep oil and gas investment stableBy Nerijus Adomaitis and Nora Buli OSLO, Feb 4 (Reuters) - Equinor EQNR.OL will cut share ...Reuters
Wed, Feb 4
Stocks
Why Dutch Bros Stock Fell 11% in January
Key PointsDutch Bros is demonstrating high growth and increasing profits.It plans to double store count by 2029.Dutch Bros stock trades at a premium price.10 stocks we like better than Dutch Bros › Shares of Dutch Bros (NYSE: BROS) stock dropped 11% in January, according to data provided by S&P Glob...The Motley Fool
Wed, Feb 4
Other
Coherus Oncology Inc - Announces Agreement With Janssen - SEC Filing
Feb 4 (Reuters) - Coherus Oncology Inc CHRS.O:COHERUS ONCOLOGY INC - ANNOUNCES AGREEMENT WITH JANSSEN - SEC FILINGCOHERUS ONCOLOGY INC: JANSSEN WILL PROVIDE PASRITAMIG TO COMPANY, WHO WILL BE SPONSOR OF PHASE 1B CLINICAL TRIALCOHERUS ONCOLOGY INC - JANSSEN AND CO EACH RETAIN ALL COMMERCIAL RIGHTS TO...Reuters
Wed, Feb 4
Stocks
Should You Buy The Trade Desk After Its 67% Slump in 2025?
Key PointsThe Trade Desk's red-hot valuation primed the stock for its steep decline.Slowing revenue growth and competition from Amazon were likely the catalysts.Now, the stock seems likely to rebound on strong earnings growth ahead.10 stocks we like better than The Trade Desk › Last year was a fanta...The Motley Fool
Wed, Feb 4
Cryptocurrencies
Close to 60% of crypto press releases linked to red flag projects
Most crypto press releases distributed through industry channels are for projects with significant credibility concerns or fraud indicators, according to a study released Tuesday. Crypto PR firm Chainstory has found that more than 60% of published crypto press releases came from high-risk or confirmed scam ventures. Only about 2% of the reviewed releases had descriptions […]Cryptopolitan
Wed, Feb 4
